Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer- cell cytotoxicity [see comments]

Autor: JH Jansen, D van der Harst, GJ Wientjens, YM Kooy-Winkelaar, A Brand, R Willemze, HC Kluin-Nelemans

Publikováno v: Blood. 80:478-483

Some B-cell neoplasms, including hairy cell leukemia (HCL), lack expression of the adhesion molecule leukocyte function antigen-1 (LFA- 1/CD11a). Additionally, HCL cells express relatively low amounts of intercellular adhesion molecule-1 (ICAM-1/CD54

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c6b5711fba53ed37d818718bcca2d1a
https://doi.org/10.1182/blood.v80.2.478.bloodjournal802478

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma

Autor: van Agthoven M, Mh, Kramer, Sonneveld P, Kg, Hem, Pc, Huijgens, Pw, Wijermans, Hc, Kluin-Nelemans, Schaafsma MR, Douwe H. Biesma, Mattijssen V, Hagenbeek A

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1100b52470872f1ab15d135d12729661
http://europepmc.org/abstract/med/16219580

Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials.

Autor: Rossetti S; Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Juul SJ; Department of Clinical Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., van der Kaaij MAE; Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands., Fortpied C; EORTC Headquarters, Brussels, Belgium., Meijnders P; Department of Radiation Oncology, Iridium Network, University of Antwerp, Antwerpen, Belgium., Aleman BMP; Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Raemaekers JMM; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Spina M; Division of Medical Oncology and Immunerelated tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Fermé C; Department of Hematology, Gustave Roussy, Villejuif, France., Renaud L; Department of Hemato-Oncology, Hôpital Saint-Louis, DMU DHI; Université de Paris, Paris, France., Casasnovas O; Department of Hematology, CHU Dijon-Bourgogne, Dijon, France., Stamatoullas A; Department of Hematology, Centre Henri Becquerel, Rouen, France., Plattel WJ; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Hutchings M; Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Maraldo MV; Department of Clinical Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (13), pp. 2035-2039. Date of Electronic Publication: 2024 Aug 12.

Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.

Autor: Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Schmid A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Christen D; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Oude Elberink HNG; Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Span LFR; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Niedoszytko M; Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland., Gorska A; Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland., Lange M; Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, Gdańsk, Poland., Gleixner KV; Division of Hematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Hadzijusufovic E; Division of Hematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department/University Clinic for Companion Animals and Horses, Internal Medicine Small Animals, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria., Stefan A; University Clinic for Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria., Angelova-Fischer I; Department of Dermatology and Venereology, Allergy Center, Kepler University Hospital, Johannes Kepler University, Linz, Austria., Zanotti R; Department of Medicine, Section of Hematology, Verona University Hospital, Verona, Italy., Bonifacio M; Department of Medicine, Section of Hematology, Verona University Hospital, Verona, Italy., Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy., Shoumariyeh K; Department of Medicine I, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany., von Bubnoff N; Department of Medicine I, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Müller S; Department of Dermatology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Perkins C; Stanford Cancer Institute, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA., Elena C; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Malcovati L; Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Hagglund H; Division of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Mattsson M; Division of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Parente R; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Varkonyi J; Department of Hematology, Semmelweis University, Budapest, Hungary., Fortina AB; Department of Medicine, Pediatric Dermatology Unit, University of Padova, Padova, Italy., Caroppo F; Department of Medicine, Pediatric Dermatology Unit, University of Padova, Padova, Italy., Brockow K; Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany., Zink A; Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany., Breynaert C; KU Leuven Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group and MASTeL, University Hospitals Leuven, Leuven, Belgium., Leven T; KU Leuven Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group and MASTeL, University Hospitals Leuven, Leuven, Belgium., Yavuz AS; Division of Hematology, Istanbul Medical School, University of Istanbul, Istanbul, Turkey., Doubek M; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sabato V; Department of Immunology-Allergology-Rheumatology, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium., Schug T; Department of Dermatology and Venereology, University Hospital Graz, Graz, Austria., Hartmann K; Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Triggiani M; Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy., Gotlib J; Stanford Cancer Institute, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA., Hermine O; French Reference Center for Mastocytosis, Hospital Necker, Assistance Publique Hôpitaux de Paris, Imagine Institute, University Paris Descartes, Paris, France., Arock M; French Reference Center for Mastocytosis, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, University Paris Sorbonne, Paris, France., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Panse J; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Sperr WR; Division of Hematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Valent P; Division of Hematology & Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Publikováno v: Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2890-2900.

Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study.

Autor: Klein SK; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Blood advances [Blood Adv] 2023 Dec 26; Vol. 7 (24), pp. 7554-7563.